Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.742
Peer-review started: November 13, 2023
First decision: December 7, 2023
Revised: December 19, 2023
Accepted: January 16, 2024
Article in press: January 16, 2024
Published online: February 21, 2024
Processing time: 100 Days and 24 Hours
In hepatology, the clinical use of endoscopic ultrasound (EUS) has experienced a notable increase in recent times. These applications range from the diagnosis to the treatment of various liver diseases. Therefore, this systematic review sum
To examine and summarize the current available evidence of the possible roles of the EUS in making a suitable diagnosis in liver diseases as well as the therapeutic accuracy and efficacy.
PubMed, Medline, Cochrane Library, Web of Science, and Google Scholar databases were extensively searched until October 2023. The methodological quality of the eligible articles was assessed using the Newcastle-Ottawa scale or Cochrane Risk of Bias tool. In addition, statistical analyses were performed using the Comprehensive Meta-Analysis software.
Overall, 45 articles on EUS were included (28 on diagnostic role and 17 on therapeutic role). Pooled analysis demonstrated that EUS diagnostic tests had an accuracy of 92.4% for focal liver lesions (FLL) and 96.6% for parenchymal liver diseases. EUS-guided liver biopsies with either fine needle aspiration or fine needle biopsy had low complication rates when sampling FLL and parenchymal liver diseases (3.1% and 8.7%, respectively). Analysis of data from four studies showed that EUS-guided liver abscess had high clinical (90.7%) and technical success (90.7%) without significant complications. Similarly, EUS-guided interventions for the treatment of gastric varices (GV) have high technical success (98%) and GV obliteration rate (84%) with few complications (15%) and rebleeding events (17%).
EUS in liver diseases is a promising technique with the potential to be considered a first-line therapeutic and diagnostic option in selected cases.
Core Tip: This is an extensive systematic review to assess the efficacy and accuracy of the endoscopic ultrasound (EUS) in dealing with different liver pathologies. The EUS guided liver abscess drainage (EUS-AD) was highly accurate (90.7%) and very safe, with more than 90% of patients experienced no complications post EUS-AD. The safety profiles of the EUS guided aspiration and EUS guided biopsy was very promising with very low complication rate. EUS guided interventions is a safe and accurate procedure and this was demonstrated in different interventions such as EUS guided gastric varies obliteration which was successful in 84% with only 15% rebreeding risk.